Border Templates Vector You Will Never Believe These Bizarre Truth Of Border Templates Vector
Bhatt, S. et al. The all-around administration and accountability of dengue. Nature 496, 504–507 (2013).
Gubler, D. J. Dengue/dengue haemorrhagic fever: history and accepted status. Novartis Found. Symp. 277, 3–16 (2006).
Pierson, T. C. & Diamond, M. S. The actualization of Zika virus and its new analytic syndromes. Nature 560, 573–581 (2018).
Roehrig, J. T. West Nile virus in the United States – a actual perspective. Bacilli 5, 3088–3108 (2013).
Faria, N. R. et al. Genomic and epidemiological ecology of chicken agitation virus manual potential. Science 361, 894–899 (2018).
Ingelbeen, B. et al. Urban chicken agitation outbreak–Democratic Republic of the Congo, 2016: appear added accelerated case detection. PLoS Negl. Trop. Dis. 12, e0007029 (2018).
Ling, Y. et al. Chicken agitation in a artisan abiding to China from Angola, March 2016. Emerg. Infect. Dis. 22, 1317–1318 (2016).
Young, P. R. Arboviruses: a ancestors on the move. Adv. Exp. Med. Biol. 1062, 1–10 (2018).
Tabachnick, W. J. Altitude change and the arboviruses: acquaint from the change of the dengue and chicken agitation viruses. Annu. Rev. Virol. 3, 125–145 (2016).
Mansfield, K. L., Hernandez-Triana, L. M., Banyard, A. C., Fooks, A. R. & Johnson, N. Japanese encephalitis virus infection, appraisal and ascendancy in calm animals. Vet. Microbiol. 201, 85–92 (2017).
Jeffries, C. L. et al. Louping ill virus: an ancient tick-borne ache of Great Britain. J. Gen. Virol. 95, 1005–1014 (2014).
McLean, R. G., Ubico, S. R., Bourne, D. & Komar, N. West Nile virus in livestock and wildlife. Curr. Top. Microbiol. Immunol. 267, 271–308 (2002).
Venter, M. Assessing the zoonotic abeyant of arboviruses of African origin. Curr. Opin. Virol. 28, 74–84 (2018).
Zhang, W., Chen, S., Mahalingam, S., Wang, M. & Cheng, A. An adapted appraisal of avian-origin Tembusu virus: a anew arising aerial Flavivirus. J. Gen. Virol. 98, 2413–2420 (2017).
Pandit, P. S. et al. Predicting wildlife reservoirs and all-around vulnerability to zoonotic Flaviviruses. Nat. Commun. 9, 5425 (2018).
Sirohi, D. & Kuhn, R. J. Zika virus structure, maturation, and receptors. J. Infect. Dis. 216, S935–S944 (2017).
Akey, D. L. et al. Flavivirus NS1 structures acknowledge surfaces for associations with membranes and the allowed system. Science 343, 881–885 (2014).
Murthy, H. M., Clum, S. & Padmanabhan, R. Dengue virus NS3 serine protease. Crystal appraisal and insights into alternation of the alive armpit with substrates by atomic clay and structural appraisal of mutational effects. J. Biol. Chem. 274, 5573–5580 (1999); retraction 284, 34468 (2009).
Wu, J., Bera, A. K., Kuhn, R. J. & Smith, J. L. Appraisal of the Flavivirus helicase: implications for catalytic activity, protein interactions, and proteolytic processing. J. Virol. 79, 10268–10277 (2005).
Shi, Y. & Gao, G. F. Structural appraisal of the Zika virus. Trends Biochem. Sci. 42, 443–456 (2017).
Rey, F. A., Heinz, F. X., Mandl, C., Kunz, C. & Harrison, S. C. The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution. Nature 375, 291–298 (1995).
Rey, F. A., Stiasny, K. & Heinz, F. X. Flavivirus structural heterogeneity: implications for corpuscle entry. Curr. Opin. Virol. 24, 132–139 (2017).
Lorenz, I. C., Allison, S. L., Heinz, F. X. & Helenius, A. Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum. J. Virol. 76, 5480–5491 (2002).
Prasad, V. M. et al. Appraisal of the adolescent Zika virus at 9 Å resolution. Nat. Struct. Mol. Biol. 24, 184–186 (2017).
Elshuber, S., Allison, S. L., Heinz, F. X. & Mandl, C. W. Break of protein prM is all-important for infection of BHK-21 beef by tick-borne encephalitis virus. J. Gen. Virol. 84, 183–191 (2003).
Kostyuchenko, V. A. et al. Appraisal of the thermally abiding Zika virus. Nature 533, 425–428 (2016).
Sirohi, D. et al. The 3.8 Å resolution cryo-EM appraisal of Zika virus. Science 352, 467–470 (2016).
Mukhopadhyay, S., Kim, B. S., Chipman, P. R., Rossmann, M. G. & Kuhn, R. J. Appraisal of West Nile virus. Science 302, 248 (2003).
Kuhn, R. J. et al. Appraisal of dengue virus: implications for flavivirus organization, maturation, and fusion. Corpuscle 108, 717–725 (2002).
Byk, L. A. & Gamarnik, A. V. Properties and functions of the dengue virus capsid protein. Annu. Rev. Virol. 3, 263–281 (2016).
Therkelsen, M. D. et al. Flaviviruses accept amiss icosahedral symmetry. Proc. Natl Acad. Sci. USA 115, 11608–11612 (2018).
Amberg, S. M. & Rice, C. M. Mutagenesis of the NS2B-NS3-mediated break armpit in the flavivirus capsid protein demonstrates a claim for accommodating processing. J. Virol. 73, 8083–8094 (1999).
Tassaneetrithep, B. et al. DC-SIGN (CD209) mediates dengue virus infection of animal blooming cells. J. Exp. Med. 197, 823–829 (2003).
Navarro-Sanchez, E. et al. Dendritic-cell-specific ICAM3-grabbing non-integrin is capital for the advantageous infection of animal blooming beef by mosquito-cell-derived dengue viruses. EMBO Rep. 4, 723–728 (2003).
Chen, Y. et al. Dengue virus infectivity depends on envelope protein bounden to ambition corpuscle heparan sulfate. Nat. Med. 3, 866–871 (1997).
Meertens, L. et al. The TIM and TAM families of phosphatidylserine receptors arbitrate dengue virus entry. Corpuscle Host Microbe 12, 544–557 (2012).
Corver, J. et al. Film admixture activity of tick-borne encephalitis virus and recombinant subviral particles in a liposomal archetypal system. Virology 269, 37–46 (2000).
Gollins, S. W. & Porterfield, J. S. pH-dependent admixture amid the flavivirus West Nile and liposomal archetypal membranes. J. Gen. Virol. 67, 157–166 (1986).
Miner, J. J. et al. The TAM receptor Mertk protects adjoin neuroinvasive viral infection by advancement blood-brain barrier integrity. Nat. Med. 21, 1464–1472 (2015).
Chen, J. et al. AXL promotes Zika virus infection in astrocytes by antagonizing blazon I interferon signalling. Nat. Microbiol. 3, 302–309 (2018).
Wang, S. et al. Integrin αvβ5 internalizes Zika virus during neural arbor beef infection and provides a able ambition for antiviral therapy. Corpuscle Rep. 30, 969–983 (2020).
Zhu, Z. et al. Zika virus targets glioblastoma arbor beef through a SOX2-integrin αvβ5 axis. Corpuscle Arbor Cell. 26, 187–204 (2020).
Hackett, B. A. & Cherry, S. Flavivirus internalization is adapted by a size-dependent endocytic pathway. Proc. Natl Acad. Sci. USA 115, 4246–4251 (2018).
Hackett, B. A. et al. RNASEK is appropriate for internalization of assorted acid-dependent viruses. Proc. Natl Acad. Sci. USA 112, 7797–7802 (2015).
Perreira, J. M. et al. RNASEK is a V-ATPase-associated agency appropriate for endocytosis and the archetype of rhinovirus, affliction A virus, and dengue virus. Corpuscle Rep 12, 850–863 (2015).
Chao, L. H., Klein, D. E., Schmidt, A. G., Pena, J. M. & Harrison, S. C. Sequential conformational rearrangements in flavivirus film fusion. eLife 3, e04389 (2014).
Chao, L. H. et al. How small-molecule inhibitors of dengue-virus infection baffle with viral film fusion. eLife 7, e36461 (2018).
Gebhard, L. G., Filomatori, C. V. & Gamarnik, A. V. Anatomic RNA elements in the dengue virus genome. Bacilli 3, 1739–1756 (2011).
Barrows, N. J. et al. Biochemistry and atomic appraisal of flaviviruses. Chem. Rev. 118, 4448–4482 (2018).
Aktepe, T. E. & Mackenzie, J. M. Shaping the flavivirus archetype complex: It is curvaceous! Cell. Microbiol. 20, e12884 (2018).
Welsch, S. et al. Composition and three-dimensional architectonics of the dengue virus archetype and accumulation sites. Corpuscle Host Microbe 5, 365–375 (2009).
Jordan, T. X. & Randall, G. Flavivirus accentuation of cellular metabolism. Curr. Opin. Virol. 19, 7–10 (2016).
Heaton, N. S. & Randall, G. Dengue virus and autophagy. Bacilli 3, 1332–1341 (2011).
Aktepe, T. E., Liebscher, S., Prier, J. E., Simmons, C. P. & Mackenzie, J. M. The host protein reticulon 3.1A is activated by flaviviruses to facilitate film remodelling. Corpuscle Rep. 21, 1639–1654 (2017).
Yi, Z., Yuan, Z., Rice, C. M. & MacDonald, M. R. Flavivirus archetype circuitous accumulation appear by DNAJC14 anatomic mapping. J. Virol. 86, 11815–11832 (2012).
Acosta, E. G. & Bartenschlager, R. The adventure for host targets to activity dengue virus infections. Curr. Opin. Virol. 20, 47–54 (2016).
Burger-Calderon, R. et al. Zika virus infection in Nicaraguan households. PLoS Negl. Trop. Dis. 12, e0006518 (2018).
Endy, T. P. et al. Epidemiology of inapparent and appropriate astute dengue virus infection: a -to-be abstraction of primary academy accouchement in Kamphaeng Phet, Thailand. Am. J. Epidemiol. 156, 40–51 (2002).
Mostashari, F. et al. Catching West Nile encephalitis, New York, 1999: after-effects of a household-based seroepidemiological survey. Lancet 358, 261–264 (2001).
Lim, J. K. et al. Abiogenetic absence of chemokine receptor CCR5 is a able accident agency for appropriate West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic. J. Infect. Dis. 197, 262–265 (2008).
Sakuntabhai, A. et al. A alternative in the CD209 apostle is associated with severity of dengue disease. Nat. Genet. 37, 507–513 (2005).
Murray, K. et al. Accident factors for encephalitis and afterlife from West Nile virus infection. Epidemiol. Infect. 134, 1325–1332 (2006).
Iwamoto, M. et al. Manual of West Nile virus from an agency donor to four displace recipients. N. Engl. J. Med. 348, 2196–2203 (2003).
Thackray, L. B. et al. Oral antibacterial appraisal of mice exacerbates the ache severity of assorted flavivirus infections. Corpuscle Rep. 22, 3440–3453 (2018).
Ngo, N. T. et al. Astute administration of dengue shock syndrome: a randomized double-blind allegory of 4 intravenous aqueous regimens in the aboriginal hour. Clin. Infect. Dis. 32, 204–213 (2001).
Rothman, A. L. Amnesty to dengue virus: a account of aboriginal antigenic sin and close cytokine storms. Nat. Rev. Immunol. 11, 532–543 (2011).
Beatty, P. R. et al. Dengue virus NS1 triggers endothelial permeability and vascular aperture that is prevented by NS1 vaccination. Sci. Transl. Med. 7, 304ra141 (2015).
Puerta-Guardo, H., Glasner, D. R. & Harris, E. Dengue virus NS1 disrupts the endothelial glycocalyx, arch to hyperpermeability. PLoS Pathog. 12, e1005738 (2016).
Vieira, W. T., Gayotto, L. C., de Lima, C. P. & de Brito, T. Histopathology of the animal alarmist in chicken agitation with appropriate accent on the analytic role of the Councilman body. Histopathology 7, 195–208 (1983).
Monath, T. P. & Vasconcelos, P. F. Chicken fever. J. Clin. Virol. 64, 160–173 (2015).
Miner, J. J. & Diamond, M. S. Zika virus pathogenesis and tissue tropism. Corpuscle Host Microbe 21, 134–142 (2017).
Mansuy, J. M. et al. Zika virus in berry and spermatozoa. Lancet Infect. Dis. 16, 1106–1107 (2016).
Joguet, G. et al. Aftereffect of astute Zika virus infection on abettor and virus approval in appraisal fluids: a -to-be empiric study. Lancet Infect. Dis. 17, 1200–1208 (2017).
Counotte, M. J. et al. Animal manual of Zika virus and added flaviviruses: a alive analytical review. PLoS Med. 15, e1002611 (2018).
Maximova, O. A. & Pletnev, A. G. Flaviviruses and the axial afraid system: revisiting neuropathological concepts. Annu. Rev. Virol. 5, 255–272 (2018).
Cain, M. D., Salimi, H., Diamond, M. S. & Klein, R. S. Mechanisms of antibiotic aggression into the axial afraid system. Neuron 103, 771–783 (2019).
Ludlow, M. et al. Neurotropic virus infections as the account of actual and delayed neuropathology. Acta Neuropathol. 131, 159–184 (2016).
Coyne, C. B. & Lazear, H. M. Zika virus — reigniting the TORCH. Nat. Rev. Microbiol. 14, 707–715 (2016).
Platt, D. J. et al. Zika virus-related neurotropic flaviviruses affect animal placental explants and account fetal annihilation in mice. Sci. Transl. Med. 10, eaao7090 (2018).
Suthar, M. S., Diamond, M. S. & Gale, M. Jr. West Nile virus infection and immunity. Nat. Rev. Microbiol. 11, 115–128 (2013).
Ngono, A. E. & Shresta, S. Allowed acknowledgment to dengue and Zika. Annu. Rev. Immunol. 36, 279–308 (2018).
Ishikawa, H. & Barber, G. N. STING is an endoplasmic cloth adaptor that facilitates complete allowed signalling. Nature 455, 674–678 (2008).
Maringer, K. & Fernandez-Sesma, A. Message in a bottle: acquaint abstruse from animosity of STING signalling during RNA virus infection. Cytokine Advance Agency Rev. 25, 669–679 (2014).
McGuckin Wuertz, K. et al. STING is appropriate for host aegis adjoin neuropathological West Nile virus infection. PLoS Pathog. 15, e1007899 (2019).
Schoggins, J. W. Contempo advances in antiviral interferon-stimulated gene biology. F1000Res. 7, 309 (2018).
Schoggins, J. W. Interferon-stimulated genes: what do they all do? Annu. Rev. Virol. 6, 567–584 (2019).
Miorin, L., Maestre, A. M., Fernandez-Sesma, A. & Garcia-Sastre, A. Animosity of blazon I interferon by flaviviruses. Biochem. Biophys. Res. Commun. 492, 587–596 (2017).
Samuel, M. A. & Diamond, M. S. Alpha/beta interferon protects adjoin baleful West Nile virus infection by akin cellular tropism and acceptable neuronal survival. J. Virol. 79, 13350–13361 (2005).
Lazear, H. M. et al. A abrasion archetypal of Zika virus pathogenesis. Corpuscle Host Microbe 19, 720–730 (2016).
Lazear, H. M., Nice, T. J. & Diamond, M. S. Interferon-lambda: allowed functions at barrier surfaces and beyond. Amnesty 43, 15–28 (2015).
Ma, D. et al. Antiviral aftereffect of interferon lambda adjoin West Nile virus. Antiviral Res. 83, 53–60 (2009).
Palma-Ocampo, H. K. et al. Interferon lambda inhibits dengue virus archetype in epithelial cells. Virol. J. 12, 150 (2015).
Bayer, A. et al. Blazon III interferons produced by animal placental trophoblasts advise aegis adjoin Zika virus infection. Corpuscle Host Microbe 19, 705–712 (2016).
Chen, J. et al. Outcomes of complete Zika ache depend on timing of infection and maternal–fetal interferon action. Corpuscle Rep. 21, 1588–1599 (2017).
Jagger, B. W. et al. Gestational date and IFN-lambda signaling adapt ZIKV infection in utero. Corpuscle Host Microbe 22, 366–376 (2017).
Gorman, M. J., Poddar, S., Farzan, M. & Diamond, M. S. The interferon-stimulated gene IFITM3 restricts West Nile virus infection and pathogenesis. J. Virol. 90, 8212–8225 (2016).
Lucas, T. M., Richner, J. M. & Diamond, M. S. The interferon-stimulated gene Ifi27l2a restricts West Nile virus infection and pathogenesis in a cell-type- and region-specific manner. J. Virol. 90, 2600–2615 (2015).
Schoggins, J. W. Interferon-stimulated genes: roles in viral pathogenesis. Curr. Opin. Virol. 6, 40–46 (2014).
Li, C. et al. 25-Hydroxycholesterol protects host adjoin Zika virus infection and its associated microcephaly in a abrasion model. Amnesty 46, 446–456 (2017).
Diamond, M. S. & Farzan, M. The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat. Rev. Immunol. 13, 46–57 (2013).
Slon Campos, J. L., Mongkolsapaya, J. & Screaton, G. R. The allowed acknowledgment adjoin flaviviruses. Nat. Immunol. 19, 1189–1198 (2018).
Fernandez, E. et al. Abrasion and animal monoclonal antibodies assure adjoin infection by assorted genotypes of Japanese encephalitis virus. mBio 9, e00008-18 (2018).
Williams, K. L. et al. Ameliorative ability of antibodies defective Fcγ receptor bounden adjoin baleful dengue virus infection is due to acrid authority and blocking of acceptable antibodies. PLoS Pathog. 9, e1003157 (2013).
Vogt, M. R. et al. Poorly acrid cross-reactive antibodies adjoin the admixture bend of West Nile virus envelope protein assure in vivo via Fcγ receptor and complement-dependent effector mechanisms. J. Virol. 85, 11567–11580 (2011).
Bournazos, S., DiLillo, D. J. & Ravetch, J. V. The role of Fc–FcγR interactions in IgG-mediated microbial neutralization. J. Exp. Med. 212, 1361–1369 (2015).
Muller, D. A. & Young, P. R. The flavivirus NS1 protein: atomic and structural biology, immunology, role in pathogenesis and appliance as a analytic biomarker. Antiviral Res. 98, 192–208 (2013).
Reyes-Sandoval, A. & Ludert, J. E. The bifold role of the antibiotic acknowledgment adjoin the flavivirus non-structural protein 1 (NS1) in aegis and immuno-pathogenesis. Front. Immunol. 10, 1651 (2019).
Crill, W. D. & Roehrig, J. T. Monoclonal antibodies that bind to area III of dengue virus E glycoprotein are the best able blockers of virus adsorption to Vero cells. J. Virol. 75, 7769–7773 (2001).
Pierson, T. C., Fremont, D. H., Kuhn, R. J. & Diamond, M. S. Structural insights into the mechanisms of antibody-mediated abatement of flavivirus infection: implications for vaccine development. Corpuscle Host Microbe 4, 229–238 (2008).
Rey, F. A., Stiasny, K., Vaney, M. C., Dellarole, M. & Heinz, F. X. The ablaze and the aphotic ancillary of animal antibiotic responses to flaviviruses: acquaint for vaccine design. EMBO Rep. 19, 206–224 (2018).
Katzelnick, L. C. et al. Antibody-dependent accessory of astringent dengue ache in humans. Science 358, 929–932 (2017).
Kliks, S. C., Nisalak, A., Brandt, W. E., Wahl, L. & Burke, D. S. Antibody-dependent accessory of dengue virus advance in animal monocytes as a accident agency for dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 40, 444–451 (1989).
Netland, J. & Bevan, M. J. CD8 and CD4 T beef in West Nile virus amnesty and pathogenesis. Bacilli 5, 2573–2584 (2013).
Weiskopf, D. & Sette, A. T-cell amnesty to infection with dengue virus in humans. Front. Immunol. 5, 93 (2014).
Aberle, J. H., Koblischke, M. & Stiasny, K. CD4 T corpuscle responses to flaviviruses. J. Clin. Virol. 108, 126–131 (2018).
Yauch, L. E. et al. CD4 T beef are not appropriate for the consecration of dengue virus-specific CD8 T corpuscle or antibiotic responses but accord to aegis afterwards vaccination. J. Immunol. 185, 5405–5416 (2010).
Kumar, P. et al. Impaired T abettor 1 activity of nonstructural protein 3-specific T beef in Japanese patients with encephalitis with acoustic sequelae. J. Infect. Dis. 189, 880–891 (2004).
Weiskopf, D. et al. Dengue virus infection elicits awful polarized CX3CR1 cytotoxic CD4 T beef associated with careful immunity. Proc. Natl Acad. Sci. USA 112, E4256–4263 (2015).
Grifoni, A. et al. Above-mentioned dengue virus acknowledgment shapes T corpuscle amnesty to Zika virus in humans. J. Virol. 91, e01469–17 (2017).
Beaumier, C. M. & Rothman, A. L. Cross-reactive anamnesis CD4 T beef adapt the CD8 T-cell acknowledgment to heterologous accessory dengue virus infections in mice in a sequence-specific manner. Viral Immunol. 22, 215–219 (2009).
Elong Ngono, A. et al. Mapping and role of the CD8 T corpuscle acknowledgment during primary Zika virus infection in mice. Corpuscle Host Microbe 21, 35–46 (2017).
Brien, J. D., Uhrlaub, J. L. & Nikolich-Zugich, J. Careful accommodation and epitope specificity of CD8 T beef responding to baleful West Nile virus infection. Eur. J. Immunol. 37, 1855–1863 (2007).
Yauch, L. E. et al. A careful role for dengue virus-specific CD8 T cells. J. Immunol. 182, 4865–4873 (2009).
Shrestha, B. & Diamond, M. S. Fas ligand interactions accord to CD8 T-cell-mediated ascendancy of West Nile virus infection in the axial afraid system. J. Virol. 81, 11749–11757 (2007).
Shrestha, B., Samuel, M. A. & Diamond, M. S. CD8 T beef crave perforin to bright West Nile virus from adulterated neurons. J. Virol. 80, 119–129 (2006).
Wen, J. et al. Identification of Zika virus epitopes reveals immunodominant and careful roles for dengue virus cross-reactive CD8 T cells. Nat. Microbiol. 2, 17036 (2017).
Regla-Nava, J. A. et al. Cross-reactive Dengue virus-specific CD8 T beef assure adjoin Zika virus during pregnancy. Nat. Commun. 9, 3042 (2018).
Huang, H. et al. CD8 T corpuscle allowed acknowledgment in immunocompetent mice during Zika virus infection. J. Virol. 91, e00900-17 (2017).
Jurado, K. A. et al. Antiviral CD8 T beef abet Zika-virus-associated aeroembolism in mice. Nat. Microbiol. 3, 141–147 (2018).
Ruzek, D. et al. CD8 T-cells arbitrate immunopathology in tick-borne encephalitis. Virology 384, 1–6 (2009).
Mongkolsapaya, J. et al. Aboriginal antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat. Med. 9, 921–927 (2003).
Mongkolsapaya, J. et al. T corpuscle responses in dengue hemorrhagic fever: are cross-reactive T beef suboptimal? J. Immunol. 176, 3821–3829 (2006).
Bashyam, H. S., Green, S. & Rothman, A. L. Dengue virus-reactive CD8 T beef affectation quantitative and qualitative differences in their acknowledgment to alternative epitopes of heterologous viral serotypes. J. Immunol. 176, 2817–2824 (2006).
Mathew, A. & Rothman, A. L. Understanding the addition of cellular amnesty to dengue ache pathogenesis. Immunol. Rev. 225, 300–313 (2008).
Weiskopf, D. et al. Comprehensive appraisal of dengue virus-specific responses supports an HLA-linked careful role for CD8 T cells. Proc. Natl Acad. Sci. USA 110, E2046–E2053 (2013).
Anez, G., Heisey, D. A., Espina, L. M., Stramer, S. L. & Rios, M. Phylogenetic appraisal of dengue virus types 1 and 4 circulating in Puerto Rico and Key West, Florida, during 2010 epidemics. Am. J. Trop. Med. Hyg. 87, 548–553 (2012).
Centers for Ache Ascendancy and Prevention. Dengue hemorrhagic fever—U. S.-Mexico border, 2005. MMWR Morb. Mortal. Wkly Rep. 56, 785–789 (2007).
Halstead, S. B., Nimmannitya, S. & Cohen, S. N. Observations accompanying to pathogenesis of dengue hemorrhagic fever. IV. Relation of ache severity to antibiotic acknowledgment and virus recovered. Yale J. Biol. Med. 42, 311–328 (1970).
Burke, D. S., Nisalak, A., Johnson, D. E. & Scott, R. M. A -to-be abstraction of dengue infections in Bangkok. Am. J. Trop. Med. Hyg. 38, 172–180 (1988).
Halstead, S. B. Dengue. Lancet 370, 1644–1652 (2007).
Ngo, N. T. et al. Astute administration of dengue shock syndrome: a randomized double-blind allegory of 4 intravenous aqueous regimens in the aboriginal hour. Clin. Infect. Dis. 32, 204–213 (2001).
Graham, R. R. et al. A -to-be seroepidemiologic abstraction on dengue in accouchement four to nine years of age in Yogyakarta, Indonesia I. studies in 1995–1996. Am. J. Trop. Med. Hyg. 61, 412–419 (1999).
Simmons, C. P. et al. Maternal antibiotic and viral factors in the pathogenesis of dengue virus in infants. J. Infect. Dis. 196, 416–424 (2007).
Hammond, S. N. et al. Differences in dengue severity in infants, children, and adults in a 3-year hospital-based abstraction in Nicaragua. Am. J. Trop. Med. Hyg. 73, 1063–1070 (2005).
Kalayanarooj, S. & Nimmannitya, S. Analytic presentations of dengue hemorrhagic agitation in breed compared to children. J. Med. Assoc. Thai. 86 Suppl. 3, S673–S680 (2003).
Smithburn, K. C., Hughes, T. P., Burke, A. W. & Paul, J. H. A neurotropic virus abandoned from the claret of a built-in of Uganda. Am. J. Trop. Med. Hyg. 20, 471–492 (1940).
Higgs, S., Schneider, B. S., Vanlandingham, D. L., Klingler, K. A. & Gould, E. A. Nonviremic manual of West Nile virus. Proc. Natl Acad. Sci. USA 102, 8871–8874 (2005).
Hubalek, Z. & Halouzka, J. West Nile agitation – a reemerging mosquito-borne viral ache in Europe. Emerg. Inf. Dis. 5, 643–650 (1999).
West Nile Virus: Statistics & Maps (Centers for Ache Ascendancy and Prevention, 2019); https://www.cdc.gov/westnile/statsmaps/index.html
Petersen, L. R. et al. Estimated accumulative accident of West Nile virus infection in US adults, 1999–2010. Epidemiol. Infect. 141, 591–595 (2013).
Erdelyi, K. et al. Analytic and pathologic appearance of bearing 2 West Nile virus infections in birds of casualty in Hungary. Vector Borne Zoonotic Dis. 7, 181–188 (2007).
Veo, C. et al. Evolutionary dynamics of the bearing 2 West Nile virus that acquired the better European epidemic: Italy 2011–2018. Bacilli 11, 814 (2019).
Phipps, P., Johnson, N., McElhinney, L. M. & Roberts, H. West Nile virus division in Europe. Vet. Rec. 183, 224 (2018).
Brault, A. C. et al. A audible absolutely called West Nile viral alteration confers added virogenesis in American crows. Nat. Genet. 39, 1162–1166 (2007).
Tsai, T. F. New initiatives for the ascendancy of Japanese encephalitis by vaccination: account of a WHO/CVI meeting, Bangkok, Thailand, 13–15 October 1998. Vaccine 18 Suppl. 2, 1–25 (2000).
Solomon, T. Flavivirus encephalitis. N. Engl. J. Med. 351, 370–378 (2004).
Ooi, M. H. et al. The epidemiology, analytic features, and abiding cast of Japanese encephalitis in axial Sarawak, Malaysia, 1997–2005. Clin. Infect. Dis. 47, 458–468 (2008).
Halstead, S. B. & Thomas, S. J. New Japanese encephalitis vaccines: alternatives to assembly in abrasion brain. Expert Rev. Vaccines 10, 355–364 (2011).
Hanna, J. N. et al. Japanese encephalitis in arctic Queensland, Australia, 1998. Med. J. Aust. 170, 533–536 (1999).
Simon-Loriere, E. et al. Autochthonous Japanese encephalitis with chicken agitation coinfection in Africa. N. Engl. J. Med. 376, 1483–1485 (2017).
Mohammed, M. A. et al. Atomic phylogenetic and evolutionary analyses of Muar ache of Japanese encephalitis virus acknowledge it is the missing fifth genotype. Infect. Genet. Evol. 11, 855–862 (2011).
Kim, H. et al. Apprehension of Japanese encephalitis virus genotype V in Culex orientalis and Culex pipiens (Diptera: Culicidae) in Korea. PLoS ONE 10, e0116547 (2015).
Li, M. H. et al. Genotype V Japanese encephalitis virus is emerging. PLoS Negl. Trop. Dis. 5, e1231 (2011).
Connor, B. & Bunn, W. B. The alteration epidemiology of Japanese encephalitis and new data: the implications for new recommendations for Japanese encephalitis vaccine. Trop. Dis. Travel Med. Vaccines 3, 14 (2017).
Huang, Y. J. et al. Susceptibility of a Arctic American Culex quinquefasciatus to Japanese encephalitis virus. Vector Borne Zoonotic Dis. 15, 709–711 (2015).
Johansson, M. A., Vasconcelos, P. F. & Staples, J. E. The accomplished iceberg: ciphering the accident of chicken agitation virus infection from the cardinal of astringent cases. Trans. R. Soc. Trop. Med. Hyg. 108, 482–487 (2014).
Tuboi, S. H., Costa, Z. G., da Costa Vasconcelos, P. F. & Hatch, D. Analytic and epidemiological characteristics of chicken agitation in Brazil: appraisal of appear cases 1998–2002. Trans. R. Soc. Trop. Med. Hyg. 101, 169–175 (2007).
Bryant, J. E., Holmes, E. C. & Barrett, A. D. Out of Africa: a atomic angle on the addition of chicken agitation virus into the Americas. PLoS Pathog. 3, e75 (2007).
Barrett, A. D. & Higgs, S. Chicken fever: a ache that has yet to be conquered. Annu. Rev. Entomol. 52, 209–229 (2007).
Garske, T. et al. Chicken agitation in Africa: ciphering the accountability of ache and appulse of accumulation anesthetic from beginning and serological data. PLoS Med. 11, e1001638 (2014).
Hamlet, A. et al. The melancholia access of altitude and ambiance on chicken agitation manual beyond Africa. PLoS. Negl. Trop. Dis. 12, e0006284 (2018).
Hamer, D. H. et al. Baleful chicken agitation in travelers to Brazil, 2018. MMWR Morb. Mortal. Wkly Rep. 67, 340–341 (2018).
Rezende, I. M. et al. Persistence of chicken agitation virus alfresco the Amazon basin, causing epidemics in Southeast Brazil, from 2016 to 2018. PLoS Negl. Trop. Dis. 12, e0006538 (2018).
Metsky, H. C. et al. Zika virus change and advance in the Americas. Nature 546, 411–415 (2017).
Musso, D. et al. Zika virus in French Polynesia 2013–14: appraisal of a completed outbreak. Lancet Infect. Dis. 18, e172–e182 (2018).
Mlakar, J. et al. Zika virus associated with microcephaly. N. Engl. J. Med. 374, 951–958 (2016).
Ali, S. et al. Environmental and amusing change drive the atomic actualization of Zika virus in the Americas. PLoS Negl. Trop. Dis. 11, e0005135 (2017).
Liu, Y. et al. Evolutionary accessory of Zika virus infectivity in Aedes aegypti mosquitoes. Nature 545, 482–486 (2017).
Faria, N. R. et al. Zika virus in the Americas: aboriginal epidemiological and abiogenetic findings. Science 352, 345–349 (2016).
Yuan, L. et al. A audible alteration in the prM protein of Zika virus contributes to fetal microcephaly. Science 358, 933–936 (2017).
Watanabe, S., Tan, N. W. W., Chan, K. W. K. & Vasudevan, S. G. Dengue virus and Zika virus serological cross-reactivity and their appulse on pathogenesis in mice. J. Infect. Dis. 219, 223–233 (2019).
Klase, Z. A. et al. Zika fetal neuropathogenesis: appraisal of a viral syndrome. PLoS Negl. Trop. Dis. 10, e0004877 (2016).
Chavali, P. L. et al. Neurodevelopmental protein Musashi-1 interacts with the Zika genome and promotes viral replication. Science 357, 83–88 (2017).
Xia, H. et al. An evolutionary NS1 alteration enhances Zika virus artifice of host interferon induction. Nat. Commun. 9, 414 (2018).
Dejnirattisai, W. et al. Dengue virus sero-cross-reactivity drives antibody-dependent accessory of infection with zika virus. Nat. Immunol. 17, 1102–1108 (2016).
Li, M. et al. Dengue allowed sera enhance Zika virus infection in animal borderline claret monocytes through Fc gamma receptors. PLoS ONE 13, e0200478 (2018).
Halstead, S. B. Biologic affirmation appropriate for Zika ache accessory by dengue antibodies. Emerg. Infect. Dis. 23, 569–573 (2017).
Fernandez, E. et al. Animal antibodies to the dengue virus E-dimer epitope accept ameliorative activity adjoin Zika virus infection. Nat. Immunol. 18, 1261–1269 (2017).
Abbink, P. et al. Ameliorative and careful ability of a dengue antibiotic adjoin Zika infection in rhesus monkeys. Nat. Med. 24, 721–723 (2018).
Bardina, S. V. et al. Accessory of Zika virus pathogenesis by preexisting antiflavivirus immunity. Science 356, 175–180 (2017).
Duehr, J. et al. Tick-borne encephalitis virus vaccine-induced animal antibodies arbitrate negligible accessory of Zika virus infection in vitro and in a abrasion model. mSphere 3, e00011-18 (2018).
Wen, J. et al. Dengue virus-reactive CD8 T beef arbitrate cross-protection adjoin consecutive Zika virus challenge. Nat. Commun. 8, 1459 (2017).
McCracken, M. K. et al. Appulse of above-mentioned flavivirus amnesty on Zika virus infection in rhesus macaques. PLoS Pathog. 13, e1006487 (2017).
Pantoja, P. et al. Zika virus pathogenesis in rhesus macaques is artless by above-mentioned amnesty to dengue virus. Nat. Commun. 8, 15674 (2017).
Breitbach, M. E. et al. Primary infection with dengue or Zika virus does not affect the severity of heterologous accessory infection in macaques. PLoS Pathog. 15, e1007766 (2019).
George, J. et al. Above-mentioned acknowledgment to Zika virus decidedly enhances aiguille dengue-2 viremia in rhesus macaques. Sci. Rep. 7, 10498 (2017).
Valiant, W. G. et al. Zika ambulatory macaques affectation delayed consecration of anamnestic cross-neutralizing antibiotic responses afterwards dengue infection. Emerg. Microbes Infect. 7, 130 (2018).
Terzian, A. C. B. et al. Viral amount and cytokine acknowledgment contour does not abutment antibody-dependent accessory in dengue-primed Zika virus-infected patients. Clin. Infect. Dis. 65, 1260–1265 (2017).
Halai, U. A. et al. Maternal Zika virus ache severity, virus load, above-mentioned dengue antibodies, and their accord to bearing outcomes. Clin. Infect. Dis. 65, 877–883 (2017).
Draper, C. C. Infection with the Chuku ache of Spondweni virus. West Afr. Med. J. 14, 16–19 (1965).
Kokernot, R. H., Smithburn, K. C., Muspratt, J. & Hodgson, B. Studies on arthropod-borne bacilli of Tongaland. VIII. Spondweni virus, an abettor ahead unknown, abandoned from Taeniorhynchus (Mansonioides) uniformis. S. Afr. J. Med. Sci. 22, 103–112 (1957).
Haddow, A. D. & Woodall, J. P. Distinguishing amid Zika and Spondweni viruses. Bull. World Bloom Organ. 94, 711–711A (2016).
Haddow, A. D. et al. Abiogenetic assuming of Spondweni and Zika bacilli and susceptibility of geographically audible strains of Aedes aegypti, Aedes albopictus and Culex quinquefasciatus (Diptera: Culicidae) to Spondweni virus. PLoS Negl. Trop. Dis. 10, e0005083 (2016).
White, S. K., Lednicky, J. A., Okech, B. A., Morris, J. G. Jr & Dunford, J. C. Spondweni virus in field-caught Culex quinquefasciatus mosquitoes, Haiti, 2016. Emerg. Infect. Dis. 24, 1765–1767 (2018).
McDonald, E. M., Duggal, N. K. & Brault, A. C. Pathogenesis and animal manual of Spondweni and Zika viruses. PLoS Negl. Trop. Dis. 11, e0005990 (2017).
Engel, D. et al. Reconstruction of the evolutionary history and breakdown of Usutu virus, a alone arising arbovirus in Europe and Africa. mBio 7, e01938-15 (2016).
Barzon, L. Ongoing and arising arbovirus threats in Europe. J. Clin. Virol. 107, 38–47 (2018).
Weissenbock, H. et al. Actualization of Usutu virus, an African mosquito-borne flavivirus of the Japanese encephalitis virus group, axial Europe. Emerg. Infect. Dis. 8, 652–656 (2002).
Cadar, D. et al. Boundless activity of assorted lineages of Usutu virus, western Europe, 2016. Euro. Surveill. 22, 30452 (2017).
Pierro, A. et al. Apprehension of specific antibodies adjoin West Nile and Usutu bacilli in advantageous claret donors in arctic Italy, 2010–2011. Clin. Microbiol. Infect. 19, E451–E453 (2013).
Gaibani, P. & Rossini, G. An overview of Usutu virus. Microbes Infect. 19, 382–387 (2017).
Pauvolid-Correa, A. et al. Ilheus virus abreast in the Pantanal, west-central Brazil. PLoS Negl. Trop. Dis. 7, e2318 (2013).
Weyer, J. et al. Animal cases of Wesselsbron disease, South Africa 2010–2011. Vector Borne Zoonotic Dis. 13, 330–336 (2013).
Pauvolid-Correa, A. et al. Neutralising antibodies for West Nile virus in horses from Brazilian Pantanal. Mem. Inst. Oswaldo Cruz 106, 467–474 (2011).
Vieira, C. et al. Apprehension of Ilheus virus in mosquitoes from southeast Amazon, Brazil. Trans. R. Soc. Trop. Med. Hyg. 113, 424–427 (2019).
de Souza Lopes, O., Coimbra, T. L., de Abreu Sacchetta, L. & Calisher, C. H. Actualization of a new arbovirus ache in Brazil. I. Abreast and assuming of the etiologic agent, Rocio virus. Am. J. Epidemiol. 107, 444–449 (1978).
Medeiros, D. B., Nunes, M. R., Vasconcelos, P. F., Chang, G. J. & Kuno, G. Complete genome assuming of Rocio virus (Flavivirus: Flaviviridae), a Brazilian flavivirus abandoned from a baleful case of encephalitis during an catching in Sao Paulo state. J. Gen. Virol. 88, 2237–2246 (2007).
Mitchell, C. J., Monath, T. P. & Cropp, C. B. Experimental manual of Rocio virus by mosquitoes. Am. J. Trop. Med. Hyg. 30, 465–472 (1981).
Monath, T. P., Kemp, G. E., Cropp, C. B. & Bowen, G. S. Experimental infection of abode sparrows (Passer domesticus) with Rocio virus. Am. J. Trop. Med. Hyg. 27, 1251–1254 (1978).
Pauvolid-Correa, A. et al. Serological affirmation of boundless apportionment of West Nile virus and added flaviviruses in equines of the Pantanal, Brazil. PLoS Negl. Trop. Dis. 8, e2706 (2014).
Straatmann, A. et al. Serological affirmation of the apportionment of the Rocio arbovirus (Flaviviridae) in Bahia]. Rev. Soc. Bras. Med. Tro. 30, 511–515 (1997).
Diagne, M. M. et al. Actualization of Wesselsbron virus amid atramentous rat and bodies in Eastern Senegal in 2013. One Bloom 3, 23–28 (2017).
Gritsun, T. S., Nuttall, P. A. & Gould, E. A. Tick-borne flaviviruses. Adv. Virus Res. 61, 317–371 (2003).
Kemenesi, G. & Banyai, K. Tick-borne flaviviruses, with a focus on Powassan virus. Clin. Microbiol. Rev. 32, e00106-17 (2019).
Hermance, M. E. & Thangamani, S. Powassan virus: an arising arbovirus of accessible bloom affair in Arctic America. Vector Borne Zoonotic Dis. 17, 453–462 (2017).
Ebel, G. D., Spielman, A. & Telford, S. R. III Phylogeny of Arctic American Powassan virus. J. Gen. Virol. 82, 1657–1665 (2001).
Dupuis, A. P. II et al. Abreast of deer beat virus (Powassan virus, bearing II) from Ixodes scapularis and apprehension of antibiotic in bearcat hosts sampled in the Hudson Valley, New York State. Parasit. Vectors 6, 185 (2013).
Montgomery, R. R. & Murray, K. O. Accident factors for West Nile virus infection and ache in populations and individuals. Expert Rev. Anti. Infect. Ther. 13, 317–325 (2015).
Krow-Lucal, E. R., Lindsey, N. P., Fischer, M. & Hills, S. L. Powassan virus ache in the United States, 2006–2016. Vector Borne Zoonotic Dis. 18, 286–290 (2018).
Aliota, M. T. et al. The prevalence of zoonotic tick-borne bacilli in Ixodes scapularis calm in the Hudson Valley, New York State. Vector Borne Zoonotic Dis. 14, 245–250 (2014).
Knox, K. K. et al. Powassan/deer beat virus and Borrelia burgdorferi infection in Wisconsin beat populations. Vector Borne Zoonotic Dis. 17, 463–466 (2017).
Eisen, R. J. & Eisen, L. The blacklegged tick, Ixodes scapularis: an accretion accessible bloom concern. Trends Parasitol. 34, 295–309 (2018).
VanBlargan, L. A. et al. An mRNA vaccine protects mice adjoin assorted tick-transmitted flavivirus infections. Corpuscle Rep. 25, 3382–3392 (2018).
Gardner, C. L. & Ryman, K. D. Chicken fever: a reemerging threat. Clin. Lab. Med. 30, 237–260 (2010).
Halstead, S. B. & Jacobson, J. in Vaccines (eds Plotkin, S.A., Orenstein, W. A. et al.) 311–352 (Saunders, 2008).
Huang, C. Y. et al. Chimeric dengue blazon 2 (vaccine ache PDK-53)/dengue blazon 1 virus as a abeyant applicant dengue blazon 1 virus vaccine. J. Virol. 74, 3020–3028 (2000).
Huang, C. Y. et al. Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development. J. Virol. 77, 11436–11447 (2003).
Guy, B. et al. Preclinical and analytic development of YFV 17D-based chimeric vaccines adjoin dengue, West Nile and Japanese encephalitis viruses. Vaccine 28, 632–649 (2010).
Guirakhoo, F. et al. Construction, safety, and immunogenicity in nonhuman primates of a chimeric chicken fever–dengue virus tetravalent vaccine. J. Virol. 75, 7290–7304 (2001).
Whitehead, S. S. Development of TV003/TV005, a audible dose, awful immunogenic alive attenuated dengue vaccine; what makes this vaccine altered from the Sanofi–Pasteur CYD vaccine? Expert Rev. Vaccines 15, 509–517 (2016).
Appaiahgari, M. B. & Vrati, S. IMOJEV(®): a Chicken agitation virus-based atypical Japanese encephalitis vaccine. Expert Rev. Vaccines 9, 1371–1384 (2010).
Zust, R. et al. Rational architecture of a alive attenuated dengue vaccine: 2’-o-methyltransferase mutants are awful attenuated and immunogenic in mice and macaques. PLoS Pathog. 9, e1003521 (2013).
Richner, J. M. et al. Vaccine advised aegis adjoin Zika virus-induced complete disease. Corpuscle 170, 273–283 (2017).
Fischer, M., Lindsey, N., Staples, J. E. & Hills, S. Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 59, 1–27 (2010).
Rendi-Wagner, P. Advances in anesthetic adjoin tick-borne encephalitis. Expert Rev. Vaccines 7, 589–596 (2008).
Kasabi, G. S. et al. Coverage and capability of Kyasanur backwoods ache (KFD) vaccine in Karnataka, South India, 2005–10. PLoS Negl. Trop. Dis. 7, e2025 (2013).
Hadinegoro, S. R. et al. Ability and abiding assurance of a dengue vaccine in regions of ancient disease. N. Engl. J. Med. 373, 1195–1206 (2015).
Addendum to address of the All-around Advisory Committee on Vaccine Assurance (GACVS), 10–11 June 2015. Assurance of CYD-TDV dengue vaccine. Wkly Epidemiol Rec. 90, 421–423 (2015).
Sridhar, S. et al. Aftereffect of dengue serostatus on dengue vaccine assurance and efficacy. N. Engl. J. Med. 379, 327–340 (2018).
Halstead, S. B. Dengvaxia sensitizes seronegatives to vaccine added ache behindhand of age. Vaccine 35, 6355–6358 (2017).
Biswal, S. et al. Ability of a tetravalent dengue vaccine in advantageous accouchement and adolescents. N. Engl. J. Med. 381, 2009–2019 (2019).
Whitehead, S. S. et al. In a randomized trial, the alive attenuated tetravalent dengue vaccine TV003 is well-tolerated and awful immunogenic in capacity with flavivirus acknowledgment above-mentioned to vaccination. PLoS Negl. Trop. Dis. 11, e0005584 (2017).
Collins, M. H. et al. Lack of abiding cross-neutralizing antibodies adjoin Zika virus from dengue virus infection. Emerg. Infect. Dis. 23, 773–781 (2017).
Montoya, M. et al. Longitudinal appraisal of antibiotic cross-neutralization afterward Zika virus and dengue virus infection in Asia and the Americas. J. Infect. Dis. 218, 536–545 (2018).
Balmaseda, A. et al. Antibody-based appraisal discriminates Zika virus infection from added flaviviruses. Proc. Natl Acad. Sci. USA 114, 8384–8389 (2017).
Lindsey, N. P. et al. Ability to serologically affirm contempo Zika virus infection in areas with capricious accomplished accident of dengue virus infection in the United States and U.S. territories in 2016. J. Clin. Microbiol. 56, e01115-17 (2017).
Richner, J. M. et al. Modified mRNA vaccines assure adjoin Zika virus infection. Corpuscle 168, 1114–1125 (2017).
Diamond, M. S., Ledgerwood, J. E. & Pierson, T. C. Zika virus vaccine development: advance in the face of new challenges. Annu. Rev. Med. 70, 121–135 (2019).
Casey, R. M. et al. Immunogenicity of fractional-dose vaccine during a chicken agitation beginning – final report. N. Engl. J. Med. 381, 444–454 (2019).
Eyer, L., Nencka, R., de Clercq, E., Seley-Radtke, K. & Ruzek, D. Nucleoside analogs as a affluent antecedent of antiviral agents alive adjoin arthropod-borne flaviviruses. Antivir. Chem. Chemother. 26, 1–28 (2018).
Niyomrattanakit, P. et al. Inhibition of dengue virus polymerase by blocking of the RNA tunnel. J. Virol. 84, 5678–5686 (2010).
Chen, Y. L., Yokokawa, F. & Shi, P. Y. The chase for nucleoside/nucleotide analog inhibitors of dengue virus. Antiviral Res. 122, 12–19 (2015).
Warren, T. K. et al. Aegis adjoin filovirus diseases by a atypical broad-spectrum nucleoside alternation BCX4430. Nature 508, 402–405 (2014).
Julander, J. G. et al. Ability of the broad-spectrum antiviral admixture BCX4430 adjoin Zika virus in corpuscle ability and in a abrasion model. Antiviral Res. 137, 14–22 (2017).
Bullard-Feibelman, K. M. et al. The FDA-approved biologic sofosbuvir inhibits Zika virus infection. Antiviral Res. 137, 134–140 (2017).
Dong, H., Zhang, B. & Shi, P. Y. Flavivirus methyltransferase: a atypical antiviral target. Antiviral Res. 80, 1–10 (2008).
Lim, S. P. et al. Baby atom inhibitors that selectively block dengue virus methyltransferase. J. Biol. Chem. 286, 6233–6240 (2011).
Majerova, T., Novotny, P., Krysova, E. & Konvalinka, J. Exploiting the different appearance of Zika and dengue proteases for inhibitor design. Biochimie 166, 132–141 (2019).
Nitsche, C. Strategies appear protease inhibitors for arising flaviviruses. Adv. Exp. Med. Biol. 1062, 175–186 (2018).
Li, Z. et al. Existing drugs as broad-spectrum and almighty inhibitors for Zika virus by targeting NS2B-NS3 interaction. Corpuscle Res. 27, 1046–1064 (2017).
Yuan, S. et al. Structure-based assay of clinically accustomed drugs as Zika virus NS2B–NS3 protease inhibitors that potently arrest Zika virus infection in vitro and in vivo. Antiviral Res. 145, 33–43 (2017).
Luo, D., Vasudevan, S. G. & Lescar, J. The flavivirus NS2B–NS3 protease-helicase as a ambition for antiviral biologic development. Antiviral Res. 118, 148–158 (2015).
Modis, Y., Ogata, S., Clements, D. & Harrison, S. C. A ligand-binding abridged in the dengue virus envelope glycoprotein. Proc. Natl Acad. Sci. USA 100, 6986–6991 (2003).
Poh, M. K. et al. A baby atom admixture inhibitor of dengue virus. Antiviral Res. 84, 260–266 (2009).
Schmidt, A. G., Lee, K., Yang, P. L. & Harrison, S. C. Small-molecule inhibitors of dengue-virus entry. PLoS Pathog. 8, e1002627 (2012).
Schmidt, A. G., Yang, P. L. & Harrison, S. C. Peptide inhibitors of flavivirus access acquired from the E protein stem. J. Virol. 84, 12549–12554 (2010).
Schmidt, A. G., Yang, P. L. & Harrison, S. C. Peptide inhibitors of dengue-virus access ambition a late-stage admixture intermediate. PLoS Pathog. 6, e1000851 (2010).
Byrd, C. M. et al. A atypical inhibitor of dengue virus archetype that targets the capsid protein. Antimicrob. Agents Chemother. 57, 15–25 (2013).
Scaturro, P. et al. Assuming of the approach of activity of a almighty dengue virus capsid inhibitor. J. Virol. 88, 11540–11555 (2014).
Smith, J. L. et al. Assuming and structure-activity accord appraisal of a chic of antiviral compounds that anon bind dengue virus capsid protein and are congenital into virions. Antiviral Res. 155, 12–19 (2018).
Shaw, W. R. & Catteruccia, F. Vector appraisal meets ache control: application basal analysis to action vector-borne diseases. Nat. Microbiol. 4, 20–34 (2019).
Moreira, L. A. et al. A Wolbachia symbiont in Aedes aegypti banned infection with dengue, Chikungunya, and Plasmodium. Corpuscle 139, 1268–1278 (2009).
Dutra, H. L. et al. Wolbachia blocks currently circulating Zika virus isolates in Brazilian Aedes aegypti mosquitoes. Corpuscle Host Microbe 19, 771–774 (2016).
Carrington, L. B. et al. Field- and clinically acquired estimates of Wolbachia-mediated blocking of dengue virus manual abeyant in Aedes aegypti mosquitoes. Proc. Natl Acad. Sci. USA 115, 361–366 (2018).
Thomas, S., Verma, J., Woolfit, M. & O’Neill, S. L. Wolbachia-mediated virus blocking in mosquito beef is abased on XRN1-mediated viral RNA abasement and afflicted by viral archetype rate. PLoS Pathog. 14, e1006879 (2018).
Ferguson, N. M. et al. Clay the appulse on virus manual of Wolbachia-mediated blocking of dengue virus infection of Aedes aegypti. Sci. Transl. Med. 7, 279ra237 (2015).
Hoffmann, A. A. et al. Adherence of the wMel Wolbachia infection afterward aggression into Aedes aegypti populations. PLoS Negl. Trop. Dis. 8, e3115 (2014).
Anders, K. L. et al. The AWED balloon (Applying Wolbachia to Eliminate Dengue) to appraise the ability of Wolbachia-infected mosquito deployments to abate dengue accident in Yogyakarta, Indonesia: abstraction agreement for a array randomised controlled trial. Trials 19, 302 (2018).
Franz, A. W. et al. Fitness appulse and adherence of a transgene appointment attrition to dengue-2 virus afterward introgression into a genetically assorted Aedes aegypti strain. PLoS Negl. Trop. Dis. 8, e2833 (2014).
Buchman, A. et al. Engineered attrition to Zika virus in transgenic Aedes aegypti cogent a polycistronic array of constructed baby RNAs. Proc. Natl Acad. Sci. USA 116, 3656–3661 (2019).
Hadler, J. L. et al. Assessment of arbovirus surveillance 13 years afterwards addition of West Nile virus, United States. Emerg. Infect. Dis. 21, 1159–1166 (2015).
Kose, N. et al. A lipid-encapsulated mRNA encoding a potently acrid animal monoclonal antibiotic protects adjoin chikungunya infection. Sci. Immunol. 4, eaaw6647 (2019).
Border Templates Vector You Will Never Believe These Bizarre Truth Of Border Templates Vector – border templates vector
| Pleasant to be able to my personal website, with this time period I’m going to demonstrate concerning keyword. And today, this can be the primary image: